Literature DB >> 16283484

Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin.

Lido Calorini1, Francesca Bianchini, Antonella Mannini, Gabriele Mugnai, Salvatore Ruggieri.   

Abstract

In the present study we investigated whether synthesis of nitric oxide (NO) by macrophages is affected by contact with tumor cells. Although it is well known that NO generated by macrophages influences different activities related to tumor progression, there is limited information on the modulatory role of tumor cells on NO release by macrophages. The experimental protocol used in our study consisted in the determination of NO secreted by macrophages, either resident or inflammatory, co-cultivated with tumor cells (B16 melanoma and L929 fibrosarcoma cells) at different cell densities and macrophage:tumor cell ratios. This experimental in vitro protocol simulates the different interactions between macrophages and tumor cells that occur during the development of a tumor mass. We found that the co-cultivation with tumor cells induced an increased secretion of NO in macrophages provided that they express an inflammatory phenotype, and they were challenged with LPS or IFNgamma/LPS. Two more variables were found to be critical in the increase of NO generation in inflammatory macrophages cultivated with tumor cells: a high cell density and a prevalence of tumor cells over macrophages. The enhancement of NO secreted in inflammatory macrophages stimulated by tumor cells was not observed in normal murine fibroblasts co-cultivated with tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283484     DOI: 10.1007/s10585-005-1263-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  42 in total

1.  Macrophage potentiation of invasive capacity of rat ascites hepatoma cells.

Authors:  M Mukai; K Shinkai; R Tateishi; Y Mori; H Akedo
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

2.  Enhancement of tumor growth in mice: evidence for the involvement of host macrophages.

Authors:  S A Kadhim; R C Rees
Journal:  Cell Immunol       Date:  1984-08       Impact factor: 4.868

3.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

4.  Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis.

Authors:  V Schirrmacher
Journal:  Immunobiology       Date:  1980-07       Impact factor: 3.144

5.  Demonstration of iNOS-mRNA and iNOS in human monocytes stimulated with cancer cells in vitro.

Authors:  M Siedlar; B Mytar; A Krzeszowiak; J Baran; M Hyszko; I Ruggiero; J Wieckiewicz; J Stachura; M Zembala
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

6.  Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide.

Authors:  M Zembala; M Siedlar; J Marcinkiewicz; J Pryjma
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

7.  Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity.

Authors:  H Jiang; C A Stewart; R W Leu
Journal:  Immunobiology       Date:  1995-04       Impact factor: 3.144

8.  Tumor-stimulated release of tumor necrosis factor-alpha by human monocyte-derived macrophages.

Authors:  R DeMarco; J E Ensor; J D Hasday
Journal:  Cell Immunol       Date:  1992-04       Impact factor: 4.868

9.  Augmentation of metastasis formation by thioglycollate-elicited macrophages.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

10.  Macrophage content of spontaneous metastases at different stages of growth.

Authors:  P J Bugelski; S P Corwin; S M North; R L Kirsh; G L Nicolson; G Poste
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

View more
  4 in total

1.  Dual role of macrophages in the response of C26 colon carcinoma cells to 5-fluorouracil administration.

Authors:  Laura Patras; Alina Sesarman; Emilia Licarete; Lavinia Luca; Marius Costel Alupei; Elena Rakosy-Tican; Manuela Banciu
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

2.  Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity.

Authors:  Flavia R F Nascimento; Eliane A Gomes; Momtchilo Russo; Ana P Lepique
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

3.  Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis.

Authors:  Silvia Peppicelli; Francesca Bianchini; Lido Calorini
Journal:  Oncol Lett       Date:  2014-06-30       Impact factor: 2.967

4.  Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation.

Authors:  Adrianna Grzelak; Ingrid Polakova; Jana Smahelova; Julie Vackova; Lucie Pekarcikova; Ruth Tachezy; Michal Smahel
Journal:  Int J Mol Sci       Date:  2018-11-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.